Healthcare Marketing Blogs

10|02|25

Unpacking the FDA’s Double Standard

In her latest op-ed for MM+M, Susan Perlbachs, Chief Creative Officer, delivers a powerful reflection on the FDA’s recent wave of untitled and warning letters—and the broader implications for how pharma is scrutinized compared to other industries. Read more.

09|25|25

Navigating the FDA’s DTC Crackdown: What Pharma Marketers Need to Know

The FDA’s recent wave of warning letters targeting direct-to-consumer (DTC) pharmaceutical advertising has sent ripples through the industry. While the agency’s actions may not make TV advertising impossible, they do signal a significant tightening of enforcement—particularly around the Clear, Conspicuous, and Neutral (CCN) standard. Read the blog to learn more.

09|24|25

Finding the Unfindable: The Artful Ingenuity of AI-Powered Patient Finding

Millions of patients remain undiagnosed or unaware of effective treatments — delaying care and leaving brands with untapped opportunity. Traditional approaches often fall short, but AI-powered patient-finding is changing the game. Our latest POV explores how a strategic combination of diverse data, cross-disciplinary clinical expertise, and advanced AI tools — what we call Artful Ingenuity […]

09|03|25

Evolving Search Engine Marketing in Pharma: A New Era of Targeting Capabilities

A Google update marks a major shift for pharma marketers, enabling the use of first-party data tools like Customer Match and Remarketing, capabilities previously restricted in sensitive categories. These changes open new doors for precision targeting of HCPs and improved ROI in paid search. Download the POV to learn how your brand can stay competitive in this evolving landscape.

08|28|25

Marketing in the Age of Uncertainty: Preparing for a Post-DTC World

As proposed legislation threatens to ban direct-to-consumer (DTC) pharmaceutical advertising, our experts offer a timely perspective on how pharma marketers can navigate this evolving landscape. In an era defined by regulatory uncertainty and shifting patient expectations, this POV outlines actionable strategies to stay compliant, connected and competitive. Download the POV to discover how marketers can lead the next chapter of healthcare engagement with agility and purpose.

08|26|25

EVERSANA Merges with Waltz Health to Create a New Force in Pharma Commercialization and Prescription Drug Access

EVERSANA and Waltz Health today announced a merger to form a unified healthcare platform that redefines pharmaceutical commercialization and patient access. The move integrates Waltz Health’s software-powered drug-price marketplaces and direct-to-payer model into EVERSANA’s global commercialization services, creating a next-generation approach for drug access and value in the U.S. healthcare system.

08|15|25

Reimagining Omnichannel: A New Blueprint for Pharma Marketing

Dan Gandor, EVP, Head of Omnichannel and Digital Transformation, is leading the conversation on what modern pharma marketing should look like. In a recent article in Pharmaceutical Commerce, he shared his insights on how omnichannel strategy has evolved, from fragmented tactics to orchestrated, customer-first experiences.  Read the blog to learn more.

08|04|25

EVERSANA Announces Development of End-to-End AI-Powered Life Sciences Marketing Agency Built on Google Cloud Technology

CHICAGO – August 4, 2025 – EVERSANA®, a leading provider of commercialization services to the global life sciences industry, today launched a groundbreaking pharmaceutical marketing AI agency running on an end-to-end AI-powered delivery platform built on Google Cloud technology. The AI Agency, actively deployed and validated for multiple pharmaceutical brands, is 80% AI-powered and automated, reducing marketing costs and […]

07|10|25

Cannes 2025: How CMOs Define The Future of Work and What’s to Come

Each year, the Cannes Lions International Festival of Creativity brings together the world’s most visionary marketers—and 2025 was no exception. Among the attendees was Angela Tenuta, Global Group President at EVERSANA INTOUCH, who shared her reflections in a recent PharmaLive article after joining peers from around the world to explore the evolving role of marketing leadership.

07|01|25

Cannes 2025: Lessons in Branding, AI and the Rise of Creator Content

In his PharmaLive article, John Kenny explores how brands have shifted from speculating about AI to integrating it into creative workflows. From collapsing production timelines to evolving influencer content, discover how AI is reshaping pharma marketing.